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The WNT signal transduction cascade controls myriad biological phenomena throughout develop-
ment and adult life of all animals. In parallel, aberrantWnt signaling underlies awide range of pathol-
ogies in humans. In this Review, we provide an update of the coreWnt/b-catenin signaling pathway,
discuss how its various components contribute to disease, and pose outstanding questions to be
addressed in the future.A Brief History of the Field
The Wnt1 gene, originally named Int-1, was identified in 1982
as a gene activated by integration of mouse mammary tumor
virus proviral DNA in virally induced breast tumors (Nusse
and Varmus, 1982). The Wnt1 proto-oncogene encodes
a secreted, cysteine-rich protein. The fly Wingless (wg) gene,
which controls segment polarity during larval development
(Nu¨sslein-Volhard and Wieschaus, 1980), was later shown to
be a homolog of Wnt1 (Rijsewijk et al., 1987). By 1994, epis-
tasis experiments examining the relationships among segment
polarity mutations delineated the core of this developmental
signal transduction cascade in Drosophila (e.g., porcupine,
dishevelled, armadillo (b-catenin), and zeste-white 3/GSK3
gene (Noordermeer et al., 1994; Peifer et al., 1994; Siegfried
et al., 1992). Injection of mouse Wnt1 mRNA into early frog
embryos caused a duplication of the body axis in Xenopus,
providing an assay to study the Wnt pathway in vertebrates
(McMahon and Moon, 1989). The combined observations
from Drosophila and Xenopus unveiled a highly conserved
signaling pathway, commonly referred to as the canonical
Wnt cascade. A few years later, major gaps in Wnt signal trans-
duction were closed with the identification of TCF/LEF tran-
scription factors as Wnt nuclear effectors (Behrens et al.,
1996; Molenaar et al., 1996) and Frizzleds as Wnt receptors
(Bhanot et al., 1996), which work together with LRPs/Arrow
as coreceptors (Wehrli et al., 2000).
The first direct connection between the Wnt pathway and
human disease came in the early 1990s. The adenomatous pol-
yposis coli (APC) gene was discovered independently in
a hereditary cancer syndrome termed familial adenomatous
polyposis (FAP; Kinzler et al., 1991; Nishisho et al., 1991).
Soon thereafter, the large cytoplasmic APC protein was found
to interact with b-catenin (Rubinfeld et al., 1993; Su et al.,
1993). Many additional pathway components and disease
connections were uncovered over the last two decades. Below,
we discuss these, taking the reader from Wnt secretion through
Wnt reception and signal transduction to the nuclear response
of the recipient cell.1192 Cell 149, June 8, 2012 ª2012 Elsevier Inc.Wnt Proteins Are Lipid Modified: Wnt Secretion Is
Complex and Involves a Dedicated Machinery
Most mammalian genomes, including the human genome,
harbor 19 Wnt genes, falling into 12 conserved Wnt subfamilies.
At least 11 of these subfamilies occur in the genome of a Cnidaria
(the sea anemone Nematostella vectensis), emphasizing the
crucial role that Wnt proteins play in organismal patterning
throughout the animal kingdom (Kusserow et al., 2005). Even
sponges contain a few Wnt genes, whereas single-cell organ-
isms do not, suggesting thatWnt signalingmay have been instru-
mental in the evolutionary origin of multicellular animals
(Petersen and Reddien, 2009), and mutations of six Wnt
genes have been identified in a variety of hereditary conditions
(Table 1).
Wnt proteins are40 kDa in size and contain many conserved
cysteines (Tanaka et al., 2002). Despite the initial discovery of
Wnt nearly 30 years ago, efficient production and biochemical
characterization of Wnt proteins remain challenging. The first
successful purification of active mouse Wnt3A revealed that
Wnts are lipid modified (Willert et al., 2003). One of these is
a mono-unsaturated fatty acid (palmitoleic acid) attached to
a conserved serine (Takada et al., 2006).
The lipids on Wnts are required for efficient signaling and may
be important for Wnt secretion (Franch-Marro et al., 2008a; Kur-
ayoshi et al., 2007; Willert et al., 2003). Most recently, the struc-
ture of the Xenopus Wnt8 protein as bound to Frizzled was
solved, revealing two domains on Wnt that interact with the
receptor (Janda et al., 2012). Interestingly, one of these domains
contains the palmitoleic acid lipid, which projects into a pocket in
the Frizzled CRD, a configuration that reinforces the importance
of the lipid for signaling. The role of the lipid is also reflected by
the requirement for Porcupine (Porc; Figure 1), a dedicated
and highly conserved component of the Wnt pathway active
only in Wnt-producing cells. Porc is a multipass transmembrane
O-acyltransferase in the ER that is essential for Wnt palmitoyla-
tion and maturation (Hofmann, 2000; Kadowaki et al., 1996).
Loss of Porcupine leads to retention of Wnt3A in the ER (Takada
et al., 2006) and a defect in Wg secretion in the Drosophila
Table 1. Human Diseases Associated with Mutations of Wnt Pathway Components after MacDonald et al. (2009) and the Wnt
Homepagea
Protein Mutation Type and Associated Human Disease(s) Key References
PORCN LOF X-linked focal dermal hypoplasia Grzeschik et al., 2007; Wang et al., 2007
WNT3 LOF tetra-amelia Niemann et al., 2004
WNT4 LOF Mullerian duct regression and virilisation Biason-Lauber et al., 2004
WNT5B LOF? type II diabetes Kanazawa et al., 2004
WNT7A LOF Fuhrmann syndrome Woods et al., 2006
WNT10A LOF odonto-onchyo-dermal hypoplasia Adaimy et al., 2007
WNT10B LOF obesity Christodoulides et al., 2006
RSPO1 LOF XX sex reversal with palmoplantar hyperkaratosis Parma et al., 2006
RSPO4 LOF autosomal-recessive anonychia and hyponychia congenita Blaydon et al., 2006
SOST LOF high bone mass, sclerosteosis, Van Buchem disease Balemans et al., 2001; Brunkow et al., 2001
Norrin (NDP) LOF familial exudative vitreoretinopathy Xu et al., 2004
LRP5 GOF (alternative splicing) hyperparathyroid tumors,
GOF high bone mass, LOF osteoporosis-pseudoglioma,
LOF eye vascular defects
Bjo¨rklund et al., 2007; Boyden et al., 2002;
Gong et al., 2001; Little et al., 2002;
Toomes et al., 2004
LRP6 LOF early coronary disease and osteoporosis Mani et al., 2007
FZD4 LOF familial exudative vitreoretinopathy Robitaille et al., 2002
FZD9 LOF Williams-Beuren Syndrome Wang et al., 1999
TSPAN12 LOF familial exudative vitreoretinopathy Nikopoulos et al., 2010; Poulter et al., 2010
APCDD1 LOF hereditary hypothrochosis simplex Shimomura et al., 2010
Axin1 LOF caudal duplication, cancer Oates et al., 2006; Satoh et al., 2000
Axin2 LOF tooth agenesis, cancer Lammi et al., 2004; Liu et al., 2000
APC LOF familial adenomatous polyposis, cancer Kinzler et al., 1991; Nishisho et al., 1991
WTX LOF Wilms tumor, LOF OCTS Jenkins et al., 2009; Major et al., 2007; Rivera et al., 2007
b-catenin GOF cancer Morin et al., 1997
LEF1 LOF sebaceous skin tumor Takeda et al., 2006
TCF4 GOF type II diabetes, colon cancer Bass et al., 2011; Grant et al., 2006
aWnt homepage, http://wnt.stanford.edu.embryo (Kadowaki et al., 1996). The human gene (PORCN) is
located on the X chromosome, and mutations lead to the rare
genetic disorder focal dermal hypoplasia (Table 1). This disease
is characterized by skin abnormalities and other developmental
defects (Grzeschik et al., 2007; Wang et al., 2007). Mutations in
the X-linked PORCN gene are lethal in males, consistent with
the early embryonic lethality due to gastrulation defects
observed in mouse knockouts (Barrott et al., 2011; Biechele
et al., 2011). Females survive with focal defects due to random
X inactivation.
The seven-transmembrane Wntless (Wls) protein provides an
essential though less understood function inWnt secretion (Ba¨n-
ziger et al., 2006; Bartscherer et al., 2006; Goodman et al., 2006).
Wls localizes to the Golgi network, endosomes, and the plasma
membrane and bindsWnt proteins (Figure 1). InWlsmutant cells,
Wg accumulates in the Golgi (Port et al., 2008). Wls is thought
to act as a sorting receptor, taking Wnt from the Golgi to the
plasma membrane. Intriguingly, there is evidence for Wls- and
Wg-containing secreted vesicles in the Drosophila neuromus-
cular junction, where the Wg protein is tethered to the outside
of the vesicles (Korkut et al., 2009). In this configuration, the
Wg protein interacts with its receptor on the receiving muscle.Whether this mode of Wg transport and signaling operates in
other contexts is presently unknown.
Several studies in C. elegans have revealed that the retromer,
an intracellular trafficking complex, is also required for Wnt
signaling (Coudreuse et al., 2006; Prasad and Clark, 2006).
One of the key functions of the retromer complex involves the
retrograde transport of specific endocytosed transmembrane
proteins back to the trans-Golgi network. Current evidence indi-
cates that the retromer retrieves endosomal Wls, which is other-
wise destined to be degraded in lysosomes, trafficking it to the
trans-Golgi network by retrograde transport (Belenkaya et al.,
2008; Franch-Marro et al., 2008b; Port et al., 2008; Yang et al.,
2008; Figure 1).
In Most Contexts, Wnts Signal over a Short Distance
In the current literature, it is often taken for granted that Wnt
signals are morphogens, molecules that exert their action across
a distance in tissues. A classical morphogen forms a gradient
that determines cell fate in a concentration-dependent manner.
The best-known example of morphogen signaling by a Wnt is
in the wing imaginal disk of Drosophila, where the Wingless
protein (Wg) is produced by a thin line of cells. The morphogenCell 149, June 8, 2012 ª2012 Elsevier Inc. 1193
Figure 1. The Wnt Secretion Machinery
Wnt proteins become lipid modified in the endoplasmic reticulum by the
Porcupine (Porc) enzyme. Further transport and secretion is dependent on the
Evi/Wntless multiple pass transmembrane protein. The Retromer complex is
necessary for recycling of the Evi/Wntless endosomal vesicles.spreads out over the tissue, controlling gene expression at
a distance. In this context, the Wg protein may act in association
with lipoprotein particles (Pana´kova´ et al., 2005; Zecca et al.,
1996). Alternatively, long-range signaling by lipid-modified Wg
in thewing is facilitated by interactions with specific binding part-
ners, such as the Swim protein (Mulligan et al., 2012).
It should be emphasized, however, that even in Drosophila,
Wg rarely acts as a long-range signal in organs other than the
wing. In the vast majority of the tissues, Wg mediates contact-
dependent signaling. In the embryo, Wg interacts with
Engrailed-positive cells that are adjacent to Wg-secreting cells
(van den Heuvel et al., 1989). Likewise, Wg acts as a short-range
signal in the neuromuscular junction (Korkut et al., 2009). In other
animals, Wnt signaling appears to occur predominantly between
cells that are close to each other, for example, in adult stem cell
niches (Strand and Micchelli, 2011; Sato et al., 2010). We
propose, therefore, that Wnts are not classical morphogens
but signals that mediate close-range signaling.
Wnt Receptors Consist of a Heterodimeric Complex
When interacting with target cells, Wnt proteins bind a heterodi-
meric receptor complex, consisting of a Frizzled (Fz) and an
LRP5/6 protein (Figure 2). The ten mammalian Fz proteins are
seven-transmembrane (7TM) receptors and have large extracel-
lular N-terminal cysteine-rich domains (CRD; Bhanot et al., 1996)
that provide a primary platform for Wnt binding (Dann et al.,
2001; Janda et al., 2012). The structure of the CRD as bound
to Wnt shows multiple binding surfaces, one of them containing1194 Cell 149, June 8, 2012 ª2012 Elsevier Inc.a hydrophobic groove that interacts with a lipid on theWnt mole-
cule (Janda et al., 2012). The Wnt-Fz interaction is promiscuous:
a single Wnt can bind multiple Fz proteins (e.g., Bhanot et al.,
1996) and vice versa, which is also borne out by the structure
of the Wnt-CRD complex (Janda et al., 2012). Fzs cooperate
with a single-pass transmembrane molecule of the LRP family
known as Arrow in Drosophila (Wehrli et al., 2000) and LRP5
and -6 in vertebrates (Pinson et al., 2000; Tamai et al., 2000).
A recent study describes two monoclonal antibodies against
LRP6 with the unexpected ability to inhibit signaling by some
Wnt proteins and enhance signaling by others. As these anti-
bodies bind nonoverlapping regions of LRP6 protein, these find-
ings suggest that Lrp6 contains separate binding sites for
different classes of Wnt proteins (Gong et al., 2010).
Like many signal transduction pathways, signaling by dimeric
Wnt receptors includes a ligand-induced conformational change
of the receptors followed by phosphorylation of key target
proteins. A crucial step in signaling is binding of Axin to the cyto-
plasmic tail of LRP6 (Mao et al., 2001; Figure 2). Axin-LRP6
binding is regulated by phosphorylation of the LRP6 tail (He
et al., 2004; Tamai et al., 2004) by at least two separate kinases,
GSK3 and CK1g. GSK3 phosphorylates the serine in the PPPSP
motif found in a number of Wnt signaling components, including
b-catenin, Axin, APC, and potentially LRPs (Zeng et al., 2005).
CK1g is anchored in the membrane by its palmitoylated C
terminus, and it phosphorylates these same proteins on residues
adjacent to the PPPSPmotif (Davidson et al., 2005). It is not clear
whether or how Wnt activates these protein kinases, but adding
Wnt protein to cells leads to CK1g-induced phosphorylation
within minutes, suggesting a direct response to the signal.
Relatively little is known on the role of Fz in Wnt reception. The
cytoplasmic part of Fz interacts with Dishevelled (Dsh; Chen
et al., 2003; Figure 2), facilitating interaction between the LRP
tail and Axin. The DIX domain on Dsh is similar to a region in
Axin, and these two DIX domains can bind each other directly
(Fiedler et al., 2011; Schwarz-Romond et al., 2007). Multimers
of receptor-bound Dsh and Axin molecules might encourage
the formation of the LRP-Fz dimer. Higher-order complexes con-
taining Wnts, receptors, and Dsh, as well as small particles of
multimerized Dsh molecules, have been detected in cells
(Schwarz-Romond et al., 2005).
Importantly, the Wnt pathway transduces signals differently
than most other pathways. In many signaling cascades, protein
phosphorylation amplifies the signal, as individual kinase mole-
cules catalyze the modification of multiple substrate molecules.
In contrast, Wnt-induced LRP6 phosphorylation titrates away
a negative regulator, Axin, providing a stoichiometric rather
than a catalytic mechanism of signal transduction. Likewise, it
has been proposed that the regulation of GSK3 by Wnt is stoi-
chiometric, caused by sequestration of the enzyme inside multi-
vesicular endosomes (Taelman et al., 2010).
Natural Wnt Inhibitors Act in Various Ways on Wnt
Receptors
Wnt/b-catenin signaling is regulated at many levels, including by
secreted proteins that antagonize the ligand. Among these are
secreted Frizzled-related proteins (sFRPs) and Wnt inhibitory
protein (WIF), both of which can bind Wnts, thereby inhibiting
Figure 2. Wnt Signaling at the Receptor and
Destruction Complex Level
(A) The current Wnt model. In the absence of Wnt,
the destruction complex resides in the cytoplasm,
where it binds and phosphorylates b-catenin. The
latter then leaves the complex to be ubiquitinated
by b-TrCP (which binds to the phosphorylated
‘‘degron’’ motif in b-catenin) and is then degraded
by the proteasome.Wnt induces the association of
Axin with phosphorylated LRP. The destruction
complex falls apart, and b-catenin is stabilized.
(B) A new model based on studying endogenous
destruction complex components (Li et al., 2012).
In the absence of Wnt, the destruction complex
resides in the cytoplasm, where it binds, phos-
phorylates, and ubiquitinates b-catenin by b-TrCP.
The proteasome recycles the complex by de-
grading b-catenin. Wnt induces the association of
the intact complex with phosphorylated LRP. After
binding to LRP, the destruction complex stills
captures and phosphorylates b-catenin, but
ubiquitination by b-TrCP is blocked. Newly
synthesized b-catenin accumulates.interactions between Wnt and Wnt receptors (Bovolenta et al.,
2008). Other Wnt inhibitors include proteins of the Dickkopf
(DKK) (Glinka et al., 1998) and the WISE/SOST families, which
antagonize signaling by binding LRP5/6. Recent biochemical
and genetic studies have argued that DKK1 disrupts Wnt-
induced Fz-LRP6 complex formation (Ellwanger et al., 2008;
Seme¨nov et al., 2008). Like DKK1, SOST can disrupt Wnt-
induced Fz-LRP6 complexes in vitro (Seme¨nov et al., 2005). As
a final example, APCDD1 is a membrane-bound glycoprotein
that inhibits Wnt signaling by binding both Wnt and LRP. It is
mutated in hereditary hypotrichosis simplex, a condition charac-
terized by hair follicle miniaturization (Shimomura et al., 2010;
Table 1). Of interest, no natural secreted inhibitors have been
identified in flies.
Mutations in Wnt Receptors and Their Antagonists
Implicate Wnt Signaling in Bone Disease
A fast-growing field connects Wnt signaling with bone biology
and disease (Table 1; reviewed in Monroe et al., 2011). This
link was first established by the discovery of LRP5 mutations
associated with osteoporosis pseudoglioma syndrome
(OPPG), a hereditary disorder characterized by low bone mass
and abnormal eye vasculature (Gong et al., 2001). Subsequently,
patients with distinct types of hereditary high bone mass
diseases were found to carry mutations in the LRP5 extracellular
domain (Boyden et al., 2002; Little et al., 2002), which render
LRP5 resistant to binding of the antagonist SOST (Ellies et al.,Cell 12006; Semenov and He, 2006) and
DKK1 (Ai et al., 2005; Table 1). Similarly,
mutations in the SOST gene cause scle-
rosteosis (Balemans et al., 2001; Brun-
kow et al., 2001; Table 1). Additional
mutations in Wnt pathway components
are observed in other hereditary
syndromes that display bone defects.
A loss-of-function mutation in LRP6 is
linked to a hereditary disorder character-ized by osteoporosis, coronary artery disease, and metabolic
syndrome (Table 1; Mani et al., 2007). WTX, an X-linked intracel-
lular inhibitor of Wnt/b-catenin signaling with known tumor
suppressor roles, is mutant in OSCS, a disease characterized
by excessive bone deposition and hardening (Jenkins et al.,
2009), whereas FZD9 is deleted in patients withWilliams–Beuren
syndrome, which is partially characterized by low bone density
(Wang et al., 1999).
Given that Wnt activates osteoblasts and influences bone
mass, secreted Wnt antagonists have become attractive targets
for antibody therapy in osteoporosis. In addition, local DKK1
production by malignant plasma cells induces osteolytic bone
lesions and pathological fractures, a major complication in
multiple myeloma (Tian et al., 2003). Multiple reports evaluate
the use of Dkk1 antibodies in animal models of this disease
complication (Monroe et al., 2011), and similar efforts are
ongoing using the WISE/SOST protein as a target.
Norrin and R-spondins, Secreted Agonists of the Wnt
Pathway, Are Involved in Disease
Two types of proteins—Norrin and R-spondins, which are unre-
lated to Wnts—act through the Fz/LRP complex as Wnt
agonists. The cysteine-knot protein Norrin is encoded by the
NDP gene. In humans, NDP mutations cause Norrie disease,
an X-linked disorder characterized by hypovascularization of
the retina and a severe loss of visual function (Berger and
Ropers, 2001). Severe retinal hypovascularization is also seen49, June 8, 2012 ª2012 Elsevier Inc. 1195
in humans carrying a homozygous loss-of-function mutation in
Lrp5 (Gong et al., 2001). A milder retinal hypovascularization
(familial exudative vitreoretinopathy or FEVR) occurs in patients
heterozygous for mutations in either Lrp5 (Robitaille et al.,
2002) or Fz4 (Toomes et al., 2004; Table 1).
Norrin is a direct ligand for the Frizzled-4/Lrp5 complex. The
vascular phenotypes in the retina of mouse knockout models
for Norrin (Richter et al., 1998), Frizzled-4 (Wang et al., 2001),
and Lrp5(Kato et al., 2002; Xia et al., 2008) resemble each other.
In addition, Norrin binds with high affinity and specificity to
Frizzled-4, whereas coexpression of Norrin, Frizzled-4, and
Lrp5 potently activates Wnt/b-catenin signaling (Xu et al.,
2004). Biochemical evidence and analyses of mice carrying
mutations in the tetraspanin family member Tspan12 provide
evidence that Tspan12 is a Norrin-specific coreceptor (Junge
et al., 2009). Indeed, several FEVR families were subsequently
found to carry mutations in the TSPAN12 gene (Nikopoulos
et al., 2010; Poulter et al., 2010).
Vertebrate genomes encode four R-spondin (Rspo) proteins,
small secreted proteins defined by two N-terminal furin domains
and a thrombospondin domain. The first evidence that Rspo
proteins potently enhance Wnt/b-catenin signals came from
Xenopus (Kazanskaya et al., 2004). Rspo1 was subsequently
found to feed into the canonical Wnt pathway, strongly
promoting intestinal crypt proliferation in vivo (Kim et al., 2005)
and in vitro (Sato et al., 2009). Together, these results support
a crucial role for R-spondins in Wnt/b-catenin signaling. Rspo
mutations have been found in two hereditary syndromes in
humans (Table 1). RSPO1 is the gene disrupted in a recessive
syndrome characterized by XX sex reversal, a skin abnormality
called palmoplantar hyperkeratosis, and predisposition to squa-
mous cell carcinomas (Parma et al., 2006). Mutations in the
RSPO4 gene are linked to congenital anonychia, severe hypo-
plasia of finger- and toenails, (Blaydon et al., 2006). Mutations
in RSPO2 have not been observed in humans, but rspo2 mouse
mutants exhibit a variety of developmental defects involving
limbs (Nam et al., 2007), lung (Bell et al., 2008), and craniofacial
anatomy (Yamada et al., 2009).
Lgr Molecules are R-Spondin Receptors that Enhance
Wnt Signaling
Recent studies have uncovered a small family of 7-TM receptors,
the Lgr5 family, whichmediate Rspo input into the canonical Wnt
pathway (Carmon et al., 2011; de Lau et al., 2011; Glinka et al.,
2011). All three studies demonstrate that the Lgr receptors
bind R-spondins with high affinity and are essential for signal
enhancement of low-dose Wnt. Lgr4 and Lgr5 proteins physi-
cally reside within Frizzled/LRP receptor complexes (de Lau
et al., 2011).
What was known previously about the Lgr proteins? Upon
the cloning of these receptors, it was noted that Lgr4, Lgr5,
and Lgr6 were related to the G-protein-coupled receptors
(GPCRs) for thyroid-stimulating hormone (TSH), follicle-stimu-
lating hormone (FSH), and luteinizing hormone (LH; Hsu et al.,
2000). These receptors contain a large N-terminal extracellular
leucine-rich repeat domain that binds the glycoprotein
hormones. Similarly, the Lgr proteins bind R-spondins through
their N-terminal ectodomain, but current evidence indicates1196 Cell 149, June 8, 2012 ª2012 Elsevier Inc.that they do not utilize G proteins (Carmon et al., 2011; de Lau
et al., 2011).
Gene knockout studies revealed that Lgr4 as well as Lgr5
mutant mice are neonatal lethal. Pleiotropic phenotypes were
observed for Lgr4 in male reproductive organs, eye, gall bladder,
kidney, hair follicles, and a variety of other organs, whereas Lgr5
mutants displayed a single abnormality of the lower jaw and
tongue (Barker and Clevers, 2010). It was subsequently found
that Lgr5 is a Wnt target gene in colon cancer and that it marks
adult stem cells in a number of actively self-renewing organs,
including the intestinal tract and the hair follicle (Barker et al.,
2009, 2010; Jaks et al., 2008). Of note, a strong genetic interac-
tion exists between Lgr4 and Lgr5, as seen in the gut of double-
mutant mice (de Lau et al., 2011; Mustata et al., 2011). Lgr6
similarly marks a rare, primitive stem cell that generates all
lineages of the skin (Snippert et al., 2010). The finding that the
Lgr proteins act as receptors for R-spondins reinforces the
intimate connection between Wnt signaling and activation of
adult stem cells (see below).
The Cytoplasmic APC/Axin Destruction Complex
RegulatesWnt Pathway Output by Controlling b-Catenin
Stability
The destruction complex regulates the stability of cytoplasmic
b-catenin, playing a key role in the signaling output of the
canonical Wnt cascade. The tumor suppressor protein Axin
acts as the scaffold of the destruction complex, interacting
with b-catenin, the tumor suppressor proteins APC and WTX,
and two constitutively active serine-threonine kinases (CK1a/d
and GSK3a/b; Figure 2). APC is a large protein that interacts
with both b-catenin and Axin. It contains three Axin-binding
motifs that are interspersed between a series of 15 and 20
amino acid repeats that bind b-catenin. Although it is clear
from studies on colorectal cancer that APC is essential for
destruction complex function, its specific molecular activity
remains unresolved. Another tumor suppressor protein involved
in destruction complex function is WTX. It is mutated in some
cases of Wilms tumor, a pediatric kidney cancer (Rivera et al.,
2007). WTX occurs in the destruction complex in which it
promotes b-catenin degradation, which would make its tumor-
suppressive properties equivalent to those of Apc and Axin
(Major et al., 2007). Its exact molecular functions in the Wnt
pathway, however, remain in debate (Regimbald-Dumas and
He, 2011).
When Fz/LRP receptors are not engaged, CK1 and GSK3
sequentially phosphorylate Axin-bound b-catenin at a series of
regularly spaced N-terminal Ser/Thr residues. The phosphory-
lated ‘‘degron’’ motif is then recognized by the F box/WD repeat
protein b-TrCP, part of an E3 ubiquitin ligase complex. As
a consequence, b-catenin is ubiquitinated and targeted for rapid
destruction by the proteasome (Aberle et al., 1997), preventing
activation of b-catenin target genes in the nucleus. Upon
receptor activation byWNT ligands, Axin is recruited to the phos-
phorylated tail of LRP. Recent data show that, through this
relocalization, the Wnt signal leads to inhibition of b-catenin
ubiquitination that normally occurs within the complex. Subse-
quently, the complex becomes saturated by the phosphorylated
form of b-catenin, leading newly synthesized b-catenin to
Figure 3. Wnt Signaling in the Nucleus
In the absence of Wnt signals, TCF occupies and represses its target genes,
helped by transcriptional corepressors such as Groucho. Upon Wnt signaling,
b-catenin replaces Groucho from TCF and recruits transcriptional coactivators
and histone modifiers such as Brg1, CBP, Cdc47, Bcl9, and Pygopus to drive
target gene expression.accumulate and translocate to the nucleus to activate target
genes (Figure 2 and Li et al., 2012).
In addition to its role in Wnt pathway, b-catenin performs
a second, unrelated role in simple epithelia. It is an essential
binding partner for the cytoplasmic tail of various cadherins,
such as E-cadherin in adhesion junctions (Peifer et al., 1992).
Though the half-life of the signaling pool of b-catenin is in the
order of minutes, the adherens junction pool is highly stable.
The adhesive and signaling properties of b-catenin are most
likely independent. Indeed, in C. elegans, the two functions of
b-catenin are performed by two different b-catenin homologs
(Korswagen et al., 2000).
Wnt Target Genes Are Controlled by the TCF/b-Catenin
Complex
The ultimate outcome of theWnt signal is shaped by those genes
whose activity is controlled through b-catenin and TCF. Upon
Wnt pathway activation, b-catenin accumulates in the cytoplasm
and then enters the nucleus, where it engages DNA-bound TCF
transcription factors (Behrens et al., 1996; Molenaar et al., 1996).
The consensus TCF cognate motif for vertebrate and Drosophila
TCF is AGATCAAAGG (van de Wetering et al., 1997), and the
widely used Wnt/TCF reporters such as pTOPflash (Korinek
et al., 1997) contain concatamers of this motif. In the Wnt ‘‘off’’
state, Tcfs interact with Groucho transcriptional repressors
(Figure 3; Cavallo et al., 1998; Roose et al., 1998), preventing
gene transcription. In the Wnt ‘‘on’’ state, the association with
b-catenin transiently converts TCF into a transcriptional activator
of its target genes, with additional modulation of TCF coming
from phosphorylation (Hikasa et al., 2010; Lee et al., 2009).
Whereas most Wnt target genes are tissue or developmental
stage specific, the Axin2 gene is generally regarded as a global
transcriptional target and therefore a general indicator of Wnt
pathway activity (Lustig et al., 2002). In Drosophila, a TCF
‘‘helper’’ site may explain some of the specificity of TCF interac-
tion with DNA (Chang et al., 2008).
Two other components of the TCF/b-catenin complex, Bcl9/
Legless and Pygopus, were first identified inDrosophila (Krampset al., 2002; Parker et al., 2002; Thompson et al., 2002), and Bcl9
has been proposed to bridge Pygopus to the N terminus of
b-catenin. Although most Wnt signaling events in Drosophila
appear to depend on Bcl9 and Pygopus, knockout studies in
mice suggest that these proteins are largely dispensable in
mammals (Brack et al., 2009; Schwab et al., 2007).
b-catenin influences gene transcription in several ways. Its C
terminus acts as a transcriptional activation domain (van de We-
tering et al., 1997). It binds histone modifiers such as CBP and
Brg-1 (reviewed in Sta¨deli et al., 2006) and Parafibromin/Hyrax,
homologs of yeast Cdc73 (Mosimann et al., 2006).
The details of how b-catenin shuttles between the cytoplasm
and the nucleus are unclear, although recent evidence suggests
a role for microtubules and active transport (Sugioka et al., 2011).
In some instances, active Wnt signaling may increase the overall
level of b-catenin without any detectable amount of the protein in
the nucleus. Measuring and modeling b-catenin-dependent
effects indicate that fold change rather than absolute levels are
critical, suggesting that even low levels of b-catenin would be
sufficient for transcriptional changes (Goentoro and Kirschner,
2009).
Wnt Signaling and Stem Cell Self-Renewal
Within the wide spectrum of Wnt effects on target cells, the role
of Wnts in maintaining stem cells has drawn particular interest.
Stem cells are defined as having the capacity to self-renew while
also producing specialized cells. These choices are primarily
dictated by extrinsic signaling factors. These extrinsic signals
and the cells that produce them comprise a niche, or signaling
center, with a short range of action capable of limiting the
number of stem cells (Losick et al., 2011). Although other niche
signals are known, such as proteins from the BMP, Hedgehog,
and Delta/Notch families, Wnt signals stand out because of their
widespread activity.
An early finding showed that mutations in mouse TCF4 lead to
loss of intestinal stem cells and subsequent breakdown of the
tissue (Korinek et al., 1998). Subsequent studies showed the
Wnt pathway to be required for a variety of specific stem cell
niches. In the hair follicle, Wnt signaling plays multiple roles in
the biology of stem cells and progenitors (DasGupta and Fuchs,
1999). Blocking Wnt signaling by overexpression of Dkk elimi-
nates hair follicles and other skin appendages, such as the
mammary gland, in a way that suggests that the tissue-specific
stem cells were primarily affected (Andl et al., 2002). In the hema-
topoietic system, overexpressing Axin lowers the numbers of
transplantable stem cells (Reya et al., 2003). Conversely, acti-
vating Wnt signaling by the use of mutant forms of b-catenin
can lead to the expansion of stem cells in both hematopoietic
and hair follicle systems (Gat et al., 1998). In another approach,
treatment of hematopoietic stem cells with isolated Wnt3a
protein increases self-renewal, as measured by clonogenic
assays and long-term reconstitution in irradiated mice (Willert
et al., 2003). Similarly, Wnt protein can expand the number of
clonogenic cells from the mammary gland, with retention of
the developmental potential of the cells when transplanted
back into animals (Zeng and Nusse, 2010). The Wnt agonist
R-Spondin can maintain stem cells in a self-renewing state
that are able to produce differentiated cells of the intestinalCell 149, June 8, 2012 ª2012 Elsevier Inc. 1197
epithelium (Sato et al., 2010). AndWnt canmediate maintenance
of pluripotency in mouse embryonic stem cells (Ten Berge et al.,
2011). Despite all of these examples, it should bementioned that
there are clear cases in which there is no role forWnts in stem cell
maintenance, particularly in the male and female germlines of
Drosophila (Losick et al., 2011).
In parallel, powerful genetic tools and lineage tracing have
provided further evidence for Wnts as critical stem cell signals.
These experiments have been based on identifying Wnt target
genes such as LGR5 and Axin2 in tissues, some of them being
expressed in putative stem cells (Snippert and Clevers, 2011).
Labeled stem cells have been detected in organs ranging from
the intestine to the stomach, the skin, the hair follicle, and the
mammary gland (Barker et al., 2007; Barker et al., 2010; van
Amerongen et al., 2012). Combined with the cell culture and
genetic data described above, the lineage tracing experiments
make a compelling case for Wnts as self-renewal signals for
many different varieties of adult stem cells.
What is the mechanism by which Wnt signals maintain stem-
ness? Is there a common underlying mode of action? Although
we cannot yet definitively answer this question, we can invoke
the fundamental concept that stem cells are intrinsically destined
to differentiate. It seems, therefore, that Wnt signals could block
the default step, the differentiation of cells, possibly by sup-
pressing differentiation-specific genes. There are indeed a few
examples of genes that are downregulated rather than activated
by Wnt signals, and gene suppression could be part of a global
mechanism of regulation controlled by Wnts. It is likely that
epigenetic control lies at the root of the mechanism for influ-
encing gene expression, enabling the stable propagation of
the state of the cells. At the same time, a conditional signal-
dependent state is required to make cells continuously depen-
dent on the signal to maintain stemness. Combined with the
limited range of the lipid-modified Wnt proteins (Willert et al.,
2003), this fits with an essential hallmark of the niche, a con-
strained environment sustaining a small number of stem cells.
There are clear implications of the connection between Wnt
and stem cells, including the use ofWnt proteins or Wnt pathway
agonists to maintain stem cells in culture. Though stem cells are
difficult to expand in a self-renewing state, adding Wnts or
R-Spondins has overcome some of these problems (Sato
et al., 2010; Zeng and Nusse, 2010; Ten Berge et al., 2011).
Likewise, Wnt reagents may have clinical applications for the
treatment of degenerative diseases.
Wnt Signaling in Cancer
Given the importance of Wnt signaling for adult stem cell
biology, it is not surprising that Wnt pathway mutations are
frequently observed in cancer, most notably of tissues that nor-
mally depend on Wnt for self-renewal or repair. Germline muta-
tions in the APC gene cause a hereditary cancer syndrome
termed familiar adenomatous polyposis (FAP; Kinzler et al.,
1991; Nishisho et al., 1991). FAP patients carry heterozygous
APC mutations. The second allele is frequently lost in individual
cells, which grow into colon adenomas, polyps, in early adult-
hood. Additional mutations in genes like kras, tp53, and smad4
induce some of these polyps to progress toward malignancy.
Most cases of sporadic colorectal cancer result from loss of1198 Cell 149, June 8, 2012 ª2012 Elsevier Inc.both APC alleles (Kinzler and Vogelstein, 1996). Loss of APC
function leads to the inappropriate stabilization of b-catenin
and the formation of constitutive complexes between b-catenin
and the intestinal TCF family member Tcf4 (Korinek et al., 1997).
In rare cases of colorectal cancers wild-type for APC, Axin2
is mutated (Liu et al., 2000), or activating point mutations in
b-catenin remove the regulatory N-terminal Ser/Thr residues
(Morin et al., 1997). Patients with hereditary Axin2 mutations
display a predisposition to colon cancer in addition to tooth
agenesis (Lammi et al., 2004). Recent global exome-sequencing
efforts have confirmed that the overwhelming majority of colo-
rectal cancers carry inactivating APC mutations (Wood et al.,
2007). In addition, this approach has revealed rare but recurrent
fusions between VTl1A and Tcf7l2, the gene encoding Tcf4,
adding yet another Wnt pathway member to the list of colon
cancer genes (Bass et al., 2011).
Activating Wnt Pathway Mutations Are Not Restricted to
Cancer of the Intestine
Loss-of-function mutations in Axin have also been found in
hepatocellular carcinomas, whereas oncogenic b-catenin muta-
tions, first described in colon cancer and melanoma (Rubinfeld
et al., 1997), occur in a wide variety of solid tumors (reviewed
in Reya and Clevers, 2005). Inactivating mutations in the TCF
family member Lef1 occur in sebaceous skin tumors (Takeda
et al., 2006). The link between stem cell biology and colon cancer
is further reinforced by several recent reports demonstrating
a link between Wnt signal strength, stem cell signature, and
cancer stem cell behavior (Merlos-Sua´rez et al., 2011; Vermeu-
len et al., 2010).
Wnt Signaling Components and Metabolic Diseases
A rapidly emerging field involves the link between Wnt signaling
and metabolism. Increased risk for type II diabetes has been
linked to specific SNPs in WNT5B (Kanazawa et al., 2004),
WNT10B (Christodoulides et al., 2006), and TCF7L2 (Grant
et al., 2006). The Tcf7l association occurs in multiple ethnic
groups, and changes in Tcf7l2 define the strongest genetic risk
determinant for this disease (Tong et al., 2009). Although the
molecular and physiological mechanism underlying this link
remains a matter of debate, a recent transgenic study in mice
suggests that metabolic risk is directly proportional to Tcf7l2
gene expression (Savic et al., 2011).
Small-Molecule Wnt Modulators
The broad involvement of Wnt signaling in disease, as outlined in
this Review, has driven extensive research efforts at targeting
the Wnt pathway with small molecules. Table 2 lists many of
the published molecules. From the perspective of blocking
Wnt signaling in cancer, the most effective target would be the
complex between TCF and b-catenin, as it is a critical junction
in signaling and operates downstream in the pathway. Disap-
pointingly, this complex has proven to be an elusive target. Its
structure reveals a large binding surface that is not readily dis-
lodged by chemical entities (Huber et al., 1997). Indeed, though
several compounds, such as PKF115-854 and CGP049090,
have been suggested to target Wnt signaling at this level (Lep-
ourcelet et al., 2004), their specificity and efficacy remain to be
Table 2. Small-Molecule Wnt Pathway Modifiers
Small Molecule Molecular Target Function Effect on Wnt Pathway Output Reference
IWP Porcupine inhibitor inhibits (Lu et al., 2009)
XAV939 tankyrase 1/Axin activates Axin inhibits (Huang et al., 2009)
IWR Axin activates Axin inhibits (Lu et al., 2009)
Pyrvinium CK1 inhibitor inhibits (Thorne et al., 2010)
SB-216763 GSK3 inhibitor activates (Coghlan et al., 2000)
BIO(6-bromoindirubin-30-oxime) GSK3 inhibitor activates (Sato et al., 2004)
ICG-001 CREB-binding protein inhibitor inhibits (Emami et al., 2004)
PKF115-584 (and several
other compounds)
TCF/b-catenin inhibitor inhibits (Lepourcelet et al., 2004)established firmly, and clinical screens of these compounds
have not been initiated.
Several screens have yielded compounds exerting an effect
on more upstream components, including Axin. The stability of
Axin is regulated, in part, by ADP ribosylation, catalyzed by Tank-
yrase. Inhibiting Tankyrase withmolecules such as IWR (Lu et al.,
2009) and XAV939 (Huang et al., 2009) increases Axin levels,
which, in turn, destabilizes b-catenin to inhibit Wnt signaling.
These molecules have been used only in laboratory experiments
thus far. As mentioned before, the stability of b-catenin is also
controlled by phosphorylation, in part regulated by CK1 gamma.
This enzyme appears to be activated by the compound Pyrvi-
nium, resulting in inhibition of the Wnt pathway and possibly
providing another reagent to interfere specifically with the
pathway (Thorne et al., 2010).
Somewhat surprisingly, there are no effective small-molecule
inhibitors of the receptors for Wnt. The notion that Fzs signal
through a G protein is not universally accepted, and whether G
protein inhibitors affect Wnt signaling remains an open question.
Likewise, although LRPs can be blocked by specific antibodies
and protein ligands such as Dkk and SOST (Gong et al., 2010),
these receptors remain difficult to target pharmacologically. At
the cytoplasmic tail of LRP, GSK3 and CK1-g are required for
critical phosphorylation events, which are associated with acti-
vation of signaling. Whereas protein kinases have proven to be
tractable drug targets in cancer (exemplified by the BRAF and
Abl kinases), specific inhibitors of CK1-g have yet to be identi-
fied. GSK3 has pleiotropic roles in Wnt signaling—promoting
pathway activation at the receptor level while also acting as
a negative regulator of b-catenin—and this makes it a problem-
atic target.
By far, the most specific small-molecule inhibitors in the Wnt
pathway block Porc, the enzyme promoting acylation of Wnt
proteins. The compound IWP2 can inactivate Porc with a high
degree of selectivity (Lu et al., 2009). As Wnt proteins lacking
lipids are not secreted, the IWP2 compound specifically blocks
Wnt production. Applications of the drug have been limited to
cell culture experiments and have demonstrated Wnt depen-
dency of stem cells in self-renewal assays (Sato et al., 2010;
Ten Berge et al., 2011). Although the hydrophobicity of the IWP
molecules precludes in vivo delivery and clinical use, ongoing
screens for variants and derivatives may overcome this hurdle.
Evidence is being unearthed that Wnt signals contribute ina paracrine mode to the growth of cancer cells or cancer stem
cells (Malanchi and Huelsken, 2009), and becausemetastasizing
tumor cells bear the hallmarks of Wnt signaling (Nguyen et al.,
2009), targeting Porc could be clinically important.
Can Wnt signaling be activated by small molecules? The most
widely used strategy has been to inactivate the GSK3 enzyme,
using compounds ranging from LiCl to Bio, CHIR, and SB-
216763 (references listed in Table 2). This approach certainly
can induce Wnt target gene expression and lead to biological
effects, but the results need to be carefully interpreted. GSK3
is involved in numerous signaling events in cells, and its inactiva-
tion has pleiotropic effects. The inhibitory effect of GSK3 inhibi-
tion on theWnt signal owes to the direct coupling of GSK3 to the
Wnt receptors by the scaffold proteins APC and Axin. There are
various reports on other chemical compounds that promote Wnt
signaling, but most of these elevate an existing Wnt signal rather
than activate the pathway in a ligand-independent manner.
To sum up, a small set of chemical compounds interfere with
Wnt signaling. Though these tools are limited, screens for such
molecules are ongoing. Moreover, our understanding of the
Wnt pathway is incomplete, leaving room for the discovery of
more components. For example, protein kinases involved in
TCF phosphorylation may provide good targets for drugs, just
like the protein kinases that act in other signaling pathways.
Ten Outstanding Questions in the Wnt Field
By reviewing the current status of Wnt signaling, we realized how
many questions in this field remain unanswered. We highlight ten
of those questions, hoping to inspire future research.
(1) What is the evolutionary origin of Wnt signals? Wnt genes
and signaling components are found in all metazoan animals,
including sponges. Given that Wnts are intercellular signals, it
is not surprising that they are not present in unicellular organ-
isms. Although the recently established Wnt-Fz structure has
not yet pointed to a particular evolutionary origin, one can spec-
ulate that Wnts have amore ancient origin, possibly derived from
enzymes secreted by prokaryotes.
(2) What is the nature of Wnt as a signal? Is the protein active
by itself, or is it packaged in membranes, together with possible
cofactors? The importance of ‘‘Wnt delivery’’ needs to be under-
stood.
(3) Where does Wnt signaling take place in cells? Whereas
Hedgehog signaling is located at the primary cilium, theCell 149, June 8, 2012 ª2012 Elsevier Inc. 1199
subcellular location of Wnt signaling events remains unknown,
though the endosomal compartment has been implicated as
a signaling center.
(4) Besides the well-studied Frizzled and LRP receptors, there
are other mechanisms for Wnt reception that involve the tyrosine
kinases ROR and RYK. There is very little insight into the mech-
anisms of action of these receptors, and they deserve more
intense study.
(5) How is the stabilized form of b-catenin ferried into the
nucleus? Is there a role for active microtubule-based transport?
(6) How does Wnt signaling coordinate cell fate changes with
changes in cell shape and polarity? This is a key question in
many developmental contexts of Wnt signaling, including stem
cells.
(7) Many different kinds of stem cells are controlled byWnts, in
such a way that self-renewal and the developmental potential of
the cells are preserved by the Wnt signal. Is there a universal
‘‘stemness’’ property conferred to cells by Wnts?
(8) How much of the genome is Wnt controlled across various
cell types? Given the broad effects of Wnt signaling and many
Wnt target cells, the total number of Wnt-controlled genes could
be significant.
(9) Are cancer stem cell behaviors controlled byWnt signaling?
The definition of cancer stem cells as being able to self-renew
the tumorigenic state but also able to differentiate suggests
that their behavior is dependent on external signals, such
as Wnts.
(10) Can we identify bona fide and effective Wnt inhibitors?
Though several molecules have been described to inhibit Wnt
signaling in cells, there is a great need for additional reagents
interfering with the Wnt pathway.ACKNOWLEDGMENTS
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